silevine

@silevine

Brand, digital & social media mixologist, marketer, photography nut, tech enthusiast. Head of Corporate Brand & Creative at . Views are my own.

Boston/Cambridge - USA
Vrijeme pridruživanja: svibanj 2008.

Tweetovi

Blokirali ste korisnika/cu @silevine

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @silevine

  1. proslijedio/la je Tweet
    3. velj

    26 days until ! But for the >300 million people worldwide living w/ a , their families, friends, caregivers & healthcare professionals and those focused on developing new treatments, every day is rare disease day. Learn more about how to !

    Poništi
  2. proslijedio/la je Tweet
    31. sij

    We’re pleased to announce that we’ve received a positive opinion from the EMA () Committee for Medicinal Products for Human Use () for our investigational therapeutic for the treatment of the acute hepatic .

    Poništi
  3. proslijedio/la je Tweet
    22. sij

    Symptoms of acute hepatic (AHP) can often lead to misdiagnoses of more common conditions such as IBS, fibromyalgia, appendicitis & endometriosis. As a result, patients often remain w/o a proper diagnosis for up to 15 yrs.

    Poništi
  4. proslijedio/la je Tweet
    3. pro 2019.

    The next PH1 of a Kind™ video has arrived! Watch as Will from Australia is encouraged by his best friend Oliver to be confident and tell others about his PH1 (primary type 1), and new friends come to realize that in most ways, Will is just like them. W/

    Poništi
  5. proslijedio/la je Tweet
    8. sij

    New year! New role? We've got >150 open roles in the US, Europe and Asia including many in research, clinical development, clinical operations, quality, medical affairs and manufacturing. Perhaps this is YOUR moment to join a leader that is also a recognized top employer.

    Poništi
  6. proslijedio/la je Tweet
    2. sij

    As we enter the new decade, we look forward to seeing the incredible biomedical breakthroughs from our industry to come and look back with pride on our contribution to the innovations of the past decade. And is just getting started!

    Poništi
  7. proslijedio/la je Tweet

    ┏━━┓┏━━┓┏━━┓┏━━┓ ┗━┓┃┃┏┓┃┗━┓┃┃┏┓┃ ┏━┛┃┃┃┃┃┏━┛┃┃┃┃┃ More Biotech Advances for Society ┃┏━┛┃┃┃┃┃┏━┛┃┃┃┃ ┃┗━┓┃┗┛┃┃┗━┓┃┗┛┃ ┗━━┛┗━━┛┗━━┛┗━━┛

    Poništi
  8. proslijedio/la je Tweet

    Thank you for donating 60 Birthday-in-a-Boxes, allowing us to reach homeless children in almost any living situation! We rely on volunteers groups to fill and assemble the hundreds of birthday boxes we send out each month. 🎂💙

    Poništi
  9. proslijedio/la je Tweet
    17. pro 2019.

    We’ll be providing additional information about the positive topline results from our ILLUMINATE-A Phase 3 study of lumasiran, an investigational therapeutic, announced this morning at 8:00 AM ET. The replay will be available following.

    Poništi
  10. proslijedio/la je Tweet
    17. pro 2019.

    We are pleased to share positive topline results from our ILLUMINATE-A Phase 3 study of lumasiran, an investigational therapeutic for the treatment of primary type 1 (PH1).

    Poništi
  11. proslijedio/la je Tweet
    16. pro 2019.

    Congratulations to our CEO on being nominated for 's "Best Biotech CEO of the Year" award!

    Poništi
  12. proslijedio/la je Tweet

    A new cholesterol-lowering drug developed by , under license from , could soon be under review with the US FDA, and an approval appears likely

    Poništi
  13. proslijedio/la je Tweet

    We all need to treasure the things that bring us together as a nation, as a people. Collectively hating on this Peloton ad is that thing.

    Poništi
  14. proslijedio/la je Tweet
    2. pro 2019.

    This is YOUR moment. It's the moment when you add your experience, skills & passion to a team that is pioneering RNAi therapeutics and changing the way that science treats disease. Learn why we've been named 's Top Employer & a Boston Globe Top Place to Work 2019

    Poništi
  15. 25. stu 2019.
    Poništi
  16. proslijedio/la je Tweet
    22. stu 2019.

    Earlier today, during our 2019 R&D Day, we shared commercial, late-stage and next wave program updates and discussed therapeutic platform advances. Read our R&D Day press release to learn more and access the replay of the webcast available later today.

    Poništi
  17. proslijedio/la je Tweet
    22. stu 2019.

    Our 2019 R&D Day (our 10th!) is in full swing in NYC. We’re providing commercial and investigational program and platform updates. You can join via webcast here: or access the replay following the event.

    Poništi
  18. 22. stu 2019.

    too! Important advancement in the field of . Come on twitterverse, let’s make it trend!

    Poništi
  19. proslijedio/la je Tweet
    15. stu 2019.

    Excited to share that we're a Top Place to Work for the 5th yr in a row! Thank you to all of our employees - your commitment to innovation, excellence & the power of positive culture is reflected in all we do. Learn about opportunities w/ us:

    Poništi
  20. proslijedio/la je Tweet
    19. stu 2019.

    We’ll be holding our 2019 R&D Day this Friday, 11/22 from 8am – 1pm ET and will be webcasting the entire event LIVE. Click the link below to see the agenda, speaker bios and access the webcast.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·